$DATS
DatChat, Inc. Stock $dats

$dats Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-Q Financial Statement

#000121390023086183 Filed on November 13, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2022 Q4
Revenue	$170.00	$175.00	$3.920K
YoY Change	-95.66%	-95.06%	-11.91%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$1.098M	$2.162M	$2.336M
YoY Change	-53.01%	-10.63%	-68.21%
% of Gross Profit
Research & Development	$287.4K	$380.0K	$256.0K
YoY Change	12.25%	46.75%
% of Gross Profit
Depreciation & Amortization	$8.250K	$10.69K	$60.27K
YoY Change	-86.31%	-82.02%	2497.84%
% of Gross Profit
Operating Expenses	$1.385M	$2.542M	$2.592M
YoY Change	-46.56%	881.76%	-64.72%
Operating Profit		-$2.542M
YoY Change		-5.21%
Interest Expense	$138.7K	$177.6K	$63.26K
YoY Change	119.19%		2711.56%
% of Operating Profit
Other Income/Expense, Net	-$63.80K	$177.6K
YoY Change		604.51%
Pretax Income	-$1.354M	-$2.365M	-$3.534M
YoY Change	-61.69%	-11.0%	-51.82%
Income Tax
% Of Pretax Income
Net Earnings	-$1.354M	-$2.365M	-$3.534M
YoY Change	-61.69%	-11.0%	-51.82%
Net Earnings / Revenue	-796441.18%	-1351188.57%	-90160.97%
Basic Earnings Per Share		-$1.13
Diluted Earnings Per Share	-$0.72	-$1.13	-$0.17
COMMON SHARES
Basic Shares Outstanding	2.103M shares	20.94M shares	20.60M shares
Diluted Shares Outstanding		2.089M shares

Balance Sheet

Concept	2023 Q4	2023 Q3	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$6.190M	$7.499M	$12.74M
YoY Change	-51.42%	-47.23%	-36.93%
Cash & Equivalents	$953.4K	$672.1K	$1.733M
Short-Term Investments	$5.237M	$6.827M	$11.01M
Other Short-Term Assets	$185.7K	$277.9K	$134.8K
YoY Change	37.8%	7.07%	-64.25%
Inventory
Prepaid Expenses	$185.7K	$277.9K	$134.8K
Receivables	$180.00	$142.00	$384.00
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$6.376M	$7.777M	$12.88M
YoY Change	-50.48%	-46.26%	-37.42%
LONG-TERM ASSETS
Property, Plant & Equipment	$130.5K	$108.5K	$79.69K
YoY Change	63.8%	26.94%	48.35%
Goodwill
YoY Change
Intangibles			$0.00
YoY Change
Long-Term Investments
YoY Change
Other Assets	$0.00	$0.00	$23.38K
YoY Change	-100.0%	-100.0%
Total Long-Term Assets	$130.5K	$198.7K	$237.6K
YoY Change	-45.06%	-84.95%	-0.18%
TOTAL ASSETS
Total Short-Term Assets	$6.376M	$7.777M	$12.88M
Total Long-Term Assets	$130.5K	$198.7K	$237.6K
Total Assets	$6.507M	$7.976M	$13.11M
YoY Change	-50.38%	-49.49%	-37.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$322.8K	$390.3K	$404.6K
YoY Change	-20.23%	2.41%	-21.75%
Accrued Expenses	$83.67K	$79.35K	$67.34K
YoY Change	24.25%	24.61%	24.94%
Deferred Revenue	$118.00	$78.00	$186.00
YoY Change	-36.56%	-97.98%	-97.9%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$406.6K	$469.7K	$473.4K
YoY Change	-14.13%	4.69%	-18.37%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$0.00	$22.85K	$83.68K
YoY Change	-100.0%	-77.64%	-44.59%
Total Long-Term Liabilities	$0.00	$22.85K	$83.68K
YoY Change	-100.0%	-77.64%	-44.59%
TOTAL LIABILITIES
Total Short-Term Liabilities	$406.6K	$469.7K	$473.4K
Total Long-Term Liabilities	$0.00	$22.85K	$83.68K
Total Liabilities	$406.6K	$492.6K	$557.1K
YoY Change	-27.03%	-10.58%	-23.79%
SHAREHOLDERS EQUITY
Retained Earnings	-$48.13M	-$46.78M	-$39.73M
YoY Change	21.16%	29.25%	44.0%
Common Stock	$210.00	$209.00	$2.060K
YoY Change	-89.81%	-89.85%	5.1%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$398.0K	$398.0K
YoY Change
Treasury Stock Shares
Shareholders Equity	$6.100M	$7.483M	$12.56M
YoY Change
Total Liabilities & Shareholders Equity	$6.507M	$7.976M	$13.11M
YoY Change	-50.38%	-49.49%	-37.0%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2022 Q4
OPERATING ACTIVITIES
Net Income	-$1.354M	-$2.365M	-$3.534M
YoY Change	-61.69%	-11.0%	-51.82%
Depreciation, Depletion And Amortization	$8.250K	$10.69K	$60.27K
YoY Change	-86.31%	-82.02%	2497.84%
Cash From Operating Activities	-$1.370M	-$1.980M	-$1.531M
YoY Change	-10.54%	-2.65%	-74.21%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$19.49K	-$233.2K
YoY Change	-100.0%	-203.23%	316.2%
Acquisitions
YoY Change
Other Investing Activities	$1.664M	$1.596M	-$3.200M
YoY Change	-152.0%	-607.08%
Cash From Investing Activities	$1.664M	$1.587M	-$2.967M
YoY Change	-156.08%	-575.54%	5194.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	0.000	1.720K	1.310K
YoY Change	-100.0%		-99.65%
NET CHANGE
Cash From Operating Activities	-1.370M	-1.980M	-1.531M
Cash From Investing Activities	1.664M	1.587M	-2.967M
Cash From Financing Activities	0.000	1.720K	1.310K
Net Change In Cash	294.3K	-390.9K	-4.497M
YoY Change	-106.54%	-83.49%	-19.92%
FREE CASH FLOW
Cash From Operating Activities	-$1.370M	-$1.980M	-$1.531M
Capital Expenditures	$0.00	$19.49K	-$233.2K
Free Cash Flow	-$1.370M	-$1.999M	-$1.298M
YoY Change	5.53%	-0.77%	-77.93%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q3	dats	Common Stockvalueone CommonStockvalueone		usd
CY2023Q3	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges		usd
CY2023Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments		usd
CY2022Q3	dats	Unrealized Gain On Shortterm Investments UnrealizedGainOnShorttermInvestments		usd
	dats	Unrealized Gain On Shortterm Investments UnrealizedGainOnShorttermInvestments		usd
CY2022Q3	dats	Unrealized Foreign Currency Translation Gain UnrealizedForeignCurrencyTranslationGain		usd
	dats	Unrealized Foreign Currency Translation Gain UnrealizedForeignCurrencyTranslationGain		usd
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2023-09-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-40729
	dei	Entity Registrant Name EntityRegistrantName	DATCHAT, INC.
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NV
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	47-2502264
	dei	Entity Address Address Line1 EntityAddressAddressLine1	204 Neilson Street
	dei	Entity Address City Or Town EntityAddressCityOrTown	New Brunswick
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NJ
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	08901
	dei	City Area Code CityAreaCode	(732)
	dei	Local Phone Number LocalPhoneNumber	374-3529
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
	dei	Entity Shell Company EntityShellCompany	false
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	2103321	shares
CY2023Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	672086	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1732956	usd
CY2023Q3	us-gaap	Short Term Investments ShortTermInvestments	6826759	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	11007997	usd
CY2023Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	142	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	384	usd
CY2023Q3	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	277928	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	134752	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	7776915	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	12876089	usd
CY2023Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	108492	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	79694	usd
CY2022Q4	dats	Digital Currencies And Other Digital Assets DigitalCurrenciesAndOtherDigitalAssets	23381	usd
CY2023Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	90254	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	134526	usd
CY2023Q3	us-gaap	Other Assets OtherAssets	198746	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	237601	usd
CY2023Q3	us-gaap	Assets Assets	7975661	usd
CY2022Q4	us-gaap	Assets Assets	13113690	usd
CY2023Q3	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	390317	usd
CY2022Q4	us-gaap	Accounts Payable And Accrued Liabilities Current AccountsPayableAndAccruedLiabilitiesCurrent	404600	usd
CY2023Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	79354	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	67338	usd
CY2023Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	78	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	186	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	469749	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	473439	usd
CY2023Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	22851	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	83675	usd
CY2023Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	22851	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	83675	usd
CY2023Q3	us-gaap	Liabilities Liabilities	492600	usd
CY2022Q4	us-gaap	Liabilities Liabilities	557114	usd
CY2023Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	20000000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	18000000	shares
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	18000000	shares
CY2023Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2094285	shares
CY2023Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2094285	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	2059717	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	2059717	shares
CY2023Q3	us-gaap	Common Stock Value CommonStockValue	209	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	206	usd
CY2023Q3	dats	Common Stock To Be Issued CommonStockToBeIssued	139	shares
CY2022Q4	dats	Common Stock To Be Issued CommonStockToBeIssued	139	shares
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	54551840	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	52285488	usd
CY2023Q3	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	66944	shares
CY2023Q3	us-gaap	Treasury Stock Value TreasuryStockValue	397969	usd
CY2023Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	108923	usd
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-46780142	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-39729118	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	7483061	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	12556576	usd
CY2023Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	7975661	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	13113690	usd
CY2023Q3	us-gaap	Revenues Revenues	175	usd
CY2022Q3	us-gaap	Revenues Revenues	3540	usd
	us-gaap	Revenues Revenues	501	usd
	us-gaap	Revenues Revenues	42296	usd
CY2023Q3	dats	Compensation And Related Expenses CompensationAndRelatedExpenses	1247302	usd
CY2022Q3	dats	Compensation And Related Expenses CompensationAndRelatedExpenses	1639886	usd
	dats	Compensation And Related Expenses CompensationAndRelatedExpenses	4177032	usd
	dats	Compensation And Related Expenses CompensationAndRelatedExpenses	5015827	usd
CY2023Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	219008	usd
CY2022Q3	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	65181	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	379410	usd
	us-gaap	Marketing And Advertising Expense MarketingAndAdvertisingExpense	645825	usd
CY2023Q3	dats	Professional And Consulting Expenses ProfessionalAndConsultingExpenses	483319	usd
CY2022Q3	dats	Professional And Consulting Expenses ProfessionalAndConsultingExpenses	482338	usd
	dats	Professional And Consulting Expenses ProfessionalAndConsultingExpenses	1060396	usd
	dats	Professional And Consulting Expenses ProfessionalAndConsultingExpenses	1947535	usd
CY2023Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	380017	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	258957	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1064049	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	258957	usd
CY2023Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	212680	usd
CY2022Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	232064	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	651461	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	712103	usd
CY2022Q3	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	7024	usd
	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	23381	usd
	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	91204	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	2542326	usd
CY2022Q3	us-gaap	Operating Expenses OperatingExpenses	2685450	usd
	us-gaap	Operating Expenses OperatingExpenses	7355729	usd
	us-gaap	Operating Expenses OperatingExpenses	8671451	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2542151	usd
CY2022Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2681910	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-7355228	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-8629155	usd
CY2023Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	206	usd
CY2022Q3	us-gaap	Investment Income Interest InvestmentIncomeInterest	4659	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	6058	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	8077	usd
	us-gaap	Variable Interest Entity Initial Consolidation Gain Or Loss VariableInterestEntityInitialConsolidationGainOrLoss	106538	usd
CY2023Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-36	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-102	usd
CY2023Q3	dats	Realized Gain On Shortterm Investments RealizedGainOnShorttermInvestments	177401	usd
CY2022Q3	dats	Realized Gain On Shortterm Investments RealizedGainOnShorttermInvestments	9702	usd
	dats	Realized Gain On Shortterm Investments RealizedGainOnShorttermInvestments	239382	usd
	dats	Realized Gain On Shortterm Investments RealizedGainOnShorttermInvestments	9702	usd
CY2022Q3	us-gaap	Gain Loss On Investments GainLossOnInvestments	10844	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	-47672	usd
	us-gaap	Gain Loss On Investments GainLossOnInvestments	7113	usd
CY2023Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	177571	usd
CY2022Q3	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	25205	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	304204	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	24892	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2364580	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2656705	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7051024	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8604263	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2364580	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2656705	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7051024	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8604263	usd
CY2023Q3	dats	Unrealized Gain On Shortterm Investments UnrealizedGainOnShorttermInvestments	-88681	usd
	dats	Unrealized Gain On Shortterm Investments UnrealizedGainOnShorttermInvestments	108889	usd
CY2023Q3	dats	Unrealized Foreign Currency Translation Gain UnrealizedForeignCurrencyTranslationGain	-724	usd
	dats	Unrealized Foreign Currency Translation Gain UnrealizedForeignCurrencyTranslationGain	34	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2453985	usd
CY2022Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2656705	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6942101	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-8604263	usd
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.13
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.29
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-3.4
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.32
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2088516	shares
CY2022Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2059742	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	2075515	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	1993808	shares
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	12556576	usd
CY2023Q1	dats	Stock Based Compensation In Connection With Stock Option Grants StockBasedCompensationInConnectionWithStockOptionGrants	603278	usd
CY2023Q1	dats	Stockbased Professional Fees In Connection With Stock Option Grants And Shares StockbasedProfessionalFeesInConnectionWithStockOptionGrantsAndShares	21900	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	100000	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-311174	usd
CY2023Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	132883	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-2399214	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	10704249	usd
CY2023Q2	dats	Stock Based Compensation In Connection With Stock Option Grants StockBasedCompensationInConnectionWithStockOptionGrants	752155	usd
CY2023Q2	dats	Stockbased Professional Fees In Connection With Stock Option Grants And Shares StockbasedProfessionalFeesInConnectionWithStockOptionGrantsAndShares	33058	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	-86795	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	65445	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-2287230	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	9180882	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	100000	usd
CY2023Q3	dats	Stock Based Compensation In Connection With Stock Option Grants StockBasedCompensationInConnectionWithStockOptionGrants	624361	usd
CY2023Q3	dats	Stockbased Professional Fees In Connection With Stock Option Grants And Shares StockbasedProfessionalFeesInConnectionWithStockOptionGrantsAndShares	30803	usd
CY2023Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-89405	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2364580	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	7483061	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	20084014	usd
CY2022Q1	dats	Stock Based Compensation In Connection With Stock Option Grants StockBasedCompensationInConnectionWithStockOptionGrants	822583	usd
CY2022Q1	dats	Stockbased Professional Fees In Connection With Stock Option Grants And Shares StockbasedProfessionalFeesInConnectionWithStockOptionGrantsAndShares	202275	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-3365846	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	17743026	usd
CY2022Q2	dats	Stock Based Compensation In Connection With Stock Option Grants StockBasedCompensationInConnectionWithStockOptionGrants	772197	usd
CY2022Q2	dats	Stockbased Professional Fees In Connection With Stock Option Grants And Shares StockbasedProfessionalFeesInConnectionWithStockOptionGrantsAndShares	35284	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1090000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2581712	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	17058795	usd
CY2022Q3	dats	Stock Based Compensation In Connection With Stock Option Grants StockBasedCompensationInConnectionWithStockOptionGrants	787585	usd
CY2022Q3	dats	Stockbased Professional Fees In Connection With Stock Option Grants And Shares StockbasedProfessionalFeesInConnectionWithStockOptionGrantsAndShares	51204	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-2656705	usd
CY2022Q3	us-gaap	Stockholders Equity StockholdersEquity	15240879	usd
	us-gaap	Net Income Loss NetIncomeLoss	-7051024	usd
	us-gaap	Net Income Loss NetIncomeLoss	-8604263	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	20687	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	67227	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	44272	usd
	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	36426	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	1979794	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2382364	usd
	dats	Stockbased Professional Fees StockbasedProfessionalFees	204041	usd
	dats	Stockbased Professional Fees StockbasedProfessionalFees	288764	usd
	dats	Gain From Initial Consolidation Of Variable Interest Entities GainFromInitialConsolidationOfVariableInterestEntities	106538	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	23381	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	91204	usd
	us-gaap	Noncash Contribution Expense NoncashContributionExpense	13831	usd
	us-gaap	Other Noncash Income OtherNoncashIncome	36394	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	239382	usd
	us-gaap	Realized Investment Gains Losses RealizedInvestmentGainsLosses	9702	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	-47672	usd
	us-gaap	Unrealized Gain Loss On Investments UnrealizedGainLossOnInvestments	7113	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-242	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-86	usd
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties	-42000	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	61456	usd
	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-117396	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-14283	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-23386	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-108	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-4997	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-48808	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-39027	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5159510	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-5727584	usd
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	9845000	usd
	us-gaap	Proceeds From Sale Of Short Term Investments ProceedsFromSaleOfShortTermInvestments	6430000	usd
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	5363163	usd
	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	14394340	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	49485	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	44475	usd
	dats	Increase In Cash From Consolidation Of Variable Interest Entities IncreaseInCashFromConsolidationOfVariableInterestEntities	64538	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	233245	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	4496890	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-8242060	usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt	-203	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	1315	usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock	1000	usd
	dats	Paymentsto Treasury Stock PaymentstoTreasuryStock	397969	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-398284	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-203	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-1060904	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-13969847	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	34	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	1732956	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	20199735	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	672086	usd
CY2022Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	6229888	usd
	dats	Intangible Assets Used To Pay Accounts Payable IntangibleAssetsUsedToPayAccountsPayable	112500	usd
	us-gaap	Stock Issued1 StockIssued1	100000	usd
	dats	Issuance Of Common Shares For Intangible Assets IssuanceOfCommonSharesForIntangibleAssets	1090000	usd
CY2023Q1	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	800	usd
CY2023Q1	dats	Percentage Of Share Issued And Outstanding PercentageOfShareIssuedAndOutstanding	0.40	pure
CY2022Q2	dats	Number Of Acquisition Share NumberOfAcquisitionShare	100000	shares
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q1	us-gaap	Variable Interest Entity Initial Consolidation Gain Or Loss VariableInterestEntityInitialConsolidationGainOrLoss	106538	usd
	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	7051024	usd
CY2023Q3	us-gaap	Cash Including Discontinued Operations CashIncludingDiscontinuedOperations	5159510	usd
CY2023Q3	dats	Accumulated Deficit For The Period AccumulatedDeficitForThePeriod	46780142	usd
CY2023Q3	us-gaap	Capital Capital	7307166	usd
CY2023Q3	us-gaap	Investments And Cash InvestmentsAndCash	672086	usd
CY2023Q3	us-gaap	Short Term Investments ShortTermInvestments	6826759	usd
	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span style="text-decoration:underline">Use of estimates</span></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of the financial statements in conformity with accounting principles generally accepted in the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues, expenses, and the related disclosures at the date of the consolidated financial statements and during the reporting period. Actual results could materially differ from these estimates. Significant estimates include assumptions used in assessing impairment of long-term assets, the valuation of intangible assets, the valuation of digital currencies and other digital assets, the valuation of lease liabilities and related right of use assets, the valuation of short-term investments, the valuation of deferred tax assets, and the fair value of non-cash equity transactions.</span></p>
CY2023Q3	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-88681	usd
	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	108889	usd
	dats	Advertising Costs AdvertisingCosts	645825	usd
CY2023Q3	us-gaap	Revenues Revenues	175	usd
CY2022Q3	us-gaap	Revenues Revenues	3540	usd
	us-gaap	Revenues Revenues	501	usd
	us-gaap	Revenues Revenues	42296	usd
CY2023Q3	dats	Related Party Amount RelatedPartyAmount	380017	usd
CY2022Q3	dats	Related Party Amount RelatedPartyAmount	258957	usd
	dats	Related Party Amount RelatedPartyAmount	1064049	usd
	dats	Related Party Amount RelatedPartyAmount	258957	usd
CY2023Q3	dats	Advertising Costs AdvertisingCosts	219008	usd
CY2022Q3	dats	Advertising Costs AdvertisingCosts	65181	usd
	dats	Advertising Costs AdvertisingCosts	379410	usd
	dats	Largest Amount Of Tax Benefit LargestAmountOfTaxBenefit	0.50	pure
CY2023Q3	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	6717870	usd
	dats	Unrealized Gains Loss On Investments UnrealizedGainsLossOnInvestments	108889	usd
CY2023Q3	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	6826759	usd
	dats	Assets And Liability Description AssetsAndLiabilityDescription	Foreign currency translationThe reporting currency of the Company is the U.S. dollar. Except for Metabizz SAS, the functional currency of the Company is the U.S. dollar. The functional currency of the Company’s VIE, Metabizz SAS, is the Columbian Peso (“COP”). For Metabizz SAS, results of operations and cash flows are translated at average exchange rates during the period, assets and liabilities are translated at the unified exchange rate at the end of the period, and equity is translated at historical exchange rates. As a result, amounts relating to assets and liabilities reported on the statements of cash flows may not necessarily agree with the changes in the corresponding balances on the balance sheets. Translation adjustments resulting from the process of translating the local currency financial statements into U.S. dollars are included in determining comprehensive loss. The cumulative translation adjustment and effect of exchange rate changes on cash for the nine months ended September 30, 2023 was $34. Transactions denominated in foreign currencies are translated into the functional currency at the exchange rates prevailing on the transaction dates. Assets and liabilities denominated in foreign currencies are translated into the functional currency at the exchange rates prevailing at the balance sheet date with any transaction gains and losses that arise from exchange rate fluctuations on transactions denominated in a currency other than the functional currency included in the results of operations as incurred.For Metabizz SAS, which is located in Columbia, asset and liability accounts on September 30, 2023 were translated at 0.000245 COP to $1.00, which was the exchange rate on the balance sheet date, and results of operations and cash flows are translated at the average exchange rates during the period of 0.000229 COP to $1.00.
CY2023Q3	us-gaap	Cash Held In Foreign Currency CashHeldInForeignCurrency	34	usd
	dats	Common Stock Warrants CommonStockWarrants	67385	shares
	dats	Common Stock Warrants CommonStockWarrants	67385	shares
	dats	Common Stock Options CommonStockOptions	166420	shares
	dats	Common Stock Options CommonStockOptions	161420	shares
	dats	Commonstockequivalents Commonstockequivalents	233805	shares
	dats	Commonstockequivalents Commonstockequivalents	228805	shares
CY2022Q4	us-gaap	Investment Owned At Cost InvestmentOwnedAtCost	10960325	usd
CY2022	dats	Unrealized Gains Loss On Investments UnrealizedGainsLossOnInvestments	47672	usd
CY2022Q4	us-gaap	Investment Owned At Fair Value InvestmentOwnedAtFairValue	11007997	usd
CY2019Q1	dats	Operating Lease Monthly Base Rent OperatingLeaseMonthlyBaseRent	2567	usd
CY2022Q4	dats	Operating Lease New Monthly Base Rent OperatingLeaseNewMonthlyBaseRent	7156	usd
CY2023Q3	dats	Annual Increase Percentage In Lease Agreement AnnualIncreasePercentageInLeaseAgreement	0.03	pure
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	68215	usd
	us-gaap	Lease And Rental Expense LeaseAndRentalExpense	70816	usd
CY2021Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	198898	usd
CY2021Q3	us-gaap	Lessee Operating Lease Remaining Lease Term LesseeOperatingLeaseRemainingLeaseTerm	P15M
CY2021Q3	us-gaap	Subordinated Borrowing Interest Rate SubordinatedBorrowingInterestRate	0.18	pure
CY2023Q3	dats	Rightof Use Office Lease RightofUseOfficeLease	198898	usd
CY2022Q4	dats	Rightof Use Office Lease RightofUseOfficeLease	198898	usd
CY2023Q3	dats	Operating Lease Right Of Use Asset Accumulated Amortization OperatingLeaseRightOfUseAssetAccumulatedAmortization	108644	usd
CY2022Q4	dats	Operating Lease Right Of Use Asset Accumulated Amortization OperatingLeaseRightOfUseAssetAccumulatedAmortization	64372	usd
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	90254	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	134526	usd
CY2023Q3	dats	Rightof Use Office Lease RightofUseOfficeLease	198898	usd
CY2022Q4	dats	Rightof Use Office Lease RightofUseOfficeLease	198898	usd
CY2023Q3	dats	Reduction Of Lease Liability ReductionOfLeaseLiability	-96693	usd
CY2022Q4	dats	Reduction Of Lease Liability ReductionOfLeaseLiability	-47885	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	102205	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	151013	usd
CY2023Q3	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	79354	usd
CY2022Q4	us-gaap	Long Term Debt And Capital Lease Obligations Current LongTermDebtAndCapitalLeaseObligationsCurrent	67338	usd
CY2023Q3	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	22851	usd
CY2022Q4	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	83675	usd
CY2023Q3	us-gaap	Operating Leases Future Minimum Payments Due Current OperatingLeasesFutureMinimumPaymentsDueCurrent	91415	usd
CY2023Q3	us-gaap	Operating Leases Future Minimum Payments Due In Two Years OperatingLeasesFutureMinimumPaymentsDueInTwoYears	23540	usd
CY2023Q3	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	114955	usd
CY2023Q3	dats	Operating Leases Future Minimum Payments Value Discount OperatingLeasesFutureMinimumPaymentsValueDiscount	12750	usd
CY2023Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	102205	usd
CY2022Q2	us-gaap	Stock Issued During Period Shares Acquisitions StockIssuedDuringPeriodSharesAcquisitions	100000	shares
CY2022Q2	dats	Acquisition Share Value AcquisitionShareValue	1090000	usd
CY2022Q2	dats	Business Acquisitions Share Price BusinessAcquisitionsSharePrice	10.9
CY2022Q2	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P5Y
CY2022Q4	us-gaap	Finite Lived Patents Gross FiniteLivedPatentsGross	1090000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	109000	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	981000	usd
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	981000	usd
CY2023Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	0	usd
CY2022Q4	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	1315	usd
	us-gaap	Repayments Of Debt RepaymentsOfDebt	1315	usd
CY2022Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	185600	usd
CY2023Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2023Q3	us-gaap	Capital Units Authorized CapitalUnitsAuthorized	38000000	shares
CY2021Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	200000	shares
	us-gaap	Stockholders Equity Note Stock Split StockholdersEquityNoteStockSplit	In August 2016, the Company designated 1.00 share of Series A Preferred Stock, par value $0.0001 per share (the “Series A Preferred Stock”), which has a stated value equal to $1.00 as may be adjusted for any stock dividends, combinations or splits. Each one (1) share of the Series A Preferred Stock shall have voting rights equal to (x) the total issued and outstanding Common Stock eligible to vote at the time of the respective vote divided by (y) forty-nine one hundredths (0.49) minus (z) the total issued and outstanding Common Stock eligible to vote at the time of the respective vote.
	us-gaap	Preferred Stock Voting Rights PreferredStockVotingRights	10
CY2023Q3	us-gaap	Preferred Stock Redemption Amount PreferredStockRedemptionAmount	10	usd
CY2023Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	2000000	usd
CY2021Q1	dats	Common Stock Shares Consideration CommonStockSharesConsideration	10000	shares
CY2021Q1	dats	Common Share Fair Values CommonShareFairValues	400000	usd
CY2021Q1	dats	Common Share Fair Value CommonShareFairValue	40
	dats	Stock Based Consulting Fees StockBasedConsultingFees	50000	usd
CY2023Q1	dats	Restricted Common Shares Issued RestrictedCommonSharesIssued	14300	shares
CY2023Q1	dats	Common Share Fair Values CommonShareFairValues	100000	usd
CY2023Q1	dats	Common Share Fair Value CommonShareFairValue	6.99
CY2022Q1	dats	Stock Option Exercisable Term StockOptionExercisableTerm	P5Y
CY2022Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	40
CY2022Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	32500	shares
CY2022Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P5Y
CY2022Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	40
	dats	Stock Options At Fair Value StockOptionsAtFairValue	751681	usd
CY2023Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P5Y
CY2023Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	21500	shares
CY2023Q1	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P2Y
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	10000	shares
CY2023Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P5Y
CY2023Q3	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	15
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	185628	usd
	us-gaap	Stock Option Exercise Price Increase StockOptionExercisePriceIncrease	4.76
	us-gaap	Stock Issued During Period Shares Share Based Compensation Forfeited StockIssuedDuringPeriodSharesShareBasedCompensationForfeited	33000	shares
CY2023Q3	us-gaap	Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions	133190	usd
	us-gaap	Professional Fees ProfessionalFees	25525	usd
	dats	Remaining Balance Of Stock Based Consulting RemainingBalanceOfStockBasedConsulting	2065555	usd
	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	2621129	usd
	dats	Stock Issued During Period Shares Issued For Service StockIssuedDuringPeriodSharesIssuedForService	147844	usd
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P0Y6M18D
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y
CY2023Q3	dats	Aggregate Intrinsic Value Stock Options Outstanding AggregateIntrinsicValueStockOptionsOutstanding	0	usd
CY2022Q4	dats	Share Based Compensation Warrants Outstanding Number ShareBasedCompensationWarrantsOutstandingNumber	67385	shares
CY2022Q4	dats	Shares Based Compensation Warrants Outstanding Weighted Average Exercise Price SharesBasedCompensationWarrantsOutstandingWeightedAverageExercisePrice	49.8
CY2023Q3	dats	Sharebased Outstanding Stock Warrants Weighted Average Remaining Contractual Term SharebasedOutstandingStockWarrantsWeightedAverageRemainingContractualTerm	P3Y7M24D
CY2023Q3	dats	Share Based Compensation Warrants Outstanding Number ShareBasedCompensationWarrantsOutstandingNumber	67385	shares
CY2023Q3	dats	Shares Based Compensation Warrants Outstanding Weighted Average Exercise Price SharesBasedCompensationWarrantsOutstandingWeightedAverageExercisePrice	49.8
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y10M24D
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	67385	shares
CY2023Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	49.8
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y10M24D
CY2023Q3	dats	Aggregate Intrinsic Value Stock Warrants Outstanding AggregateIntrinsicValueStockWarrantsOutstanding	0	usd
CY2021Q3	us-gaap	Accrued Salaries Current And Noncurrent AccruedSalariesCurrentAndNoncurrent	450000	usd
CY2021Q3	us-gaap	Accrued Bonuses Current And Noncurrent AccruedBonusesCurrentAndNoncurrent	350000	usd
CY2023Q3	dats	Digital Currencies And Other Digital Assets DigitalCurrenciesAndOtherDigitalAssets		usd
CY2023Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q3	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue		usd
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares		shares
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax		usd
CY2022Q3	us-gaap	Variable Interest Entity Initial Consolidation Gain Or Loss VariableInterestEntityInitialConsolidationGainOrLoss		usd
	us-gaap	Variable Interest Entity Initial Consolidation Gain Or Loss VariableInterestEntityInitialConsolidationGainOrLoss		usd
CY2022Q3	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax		usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax		usd
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.13
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	1993808	shares
CY2023Q1	dats	Common Stocks Amount Rounding CommonStocksAmountRounding		usd
CY2023Q3	dats	Common Stocks Amount Rounding CommonStocksAmountRounding		usd
	dats	Gain From Initial Consolidation Of Variable Interest Entities GainFromInitialConsolidationOfVariableInterestEntities		usd
	us-gaap	Noncash Contribution Expense NoncashContributionExpense		usd
	us-gaap	Other Noncash Income OtherNoncashIncome		usd
	us-gaap	Increase Decrease In Accounts Receivable Related Parties IncreaseDecreaseInAccountsReceivableRelatedParties		usd
	dats	Increase In Cash From Consolidation Of Variable Interest Entities IncreaseInCashFromConsolidationOfVariableInterestEntities		usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets		usd
	us-gaap	Proceeds From Repayments Of Related Party Debt ProceedsFromRepaymentsOfRelatedPartyDebt		usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable		usd
	us-gaap	Proceeds From Issuance Of Preferred Stock And Preference Stock ProceedsFromIssuanceOfPreferredStockAndPreferenceStock		usd
	dats	Paymentsto Treasury Stock PaymentstoTreasuryStock		usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Interest Paid Net InterestPaidNet		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid		usd
	dats	Intangible Assets Used To Pay Accounts Payable IntangibleAssetsUsedToPayAccountsPayable		usd
	us-gaap	Stock Issued1 StockIssued1		usd
	dats	Issuance Of Common Shares For Intangible Assets IssuanceOfCommonSharesForIntangibleAssets		usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill		usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
	dats	Weighted Average Remaining Contractual Life Years Granted WeightedAverageRemainingContractualLifeYearsGranted
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001648960

Files In Submission

Name	View Source	Status
dats-20230930_cal.xml	Edgar Link	unprocessable
dats-20230930_def.xml	Edgar Link	unprocessable
dats-20230930_lab.xml	Edgar Link	unprocessable
0001213900-23-086183-index-headers.html	Edgar Link	pending
0001213900-23-086183-index.html	Edgar Link	pending
0001213900-23-086183.txt	Edgar Link	pending
0001213900-23-086183-xbrl.zip	Edgar Link	pending
dats-20230930.xsd	Edgar Link	pending
ex3-1_001.jpg	Edgar Link	pending
ex3-1_002.jpg	Edgar Link	pending
f10q0923ex3-1_datchat.htm	Edgar Link	pending
f10q0923ex31-1_datchat.htm	Edgar Link	pending
f10q0923ex31-2_datchat.htm	Edgar Link	pending
f10q0923ex32-1_datchat.htm	Edgar Link	pending
f10q0923ex32-2_datchat.htm	Edgar Link	pending
f10q0923ex4-1_datchat.htm	Edgar Link	pending
f10q0923_datchat.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
f10q0923_datchat_htm.xml	Edgar Link	completed
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
dats-20230930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$DATS
DatChat, Inc. Stock $dats

2023 Q4 Form 10-Q Financial Statement

#000121390023086183 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DATS DatChat, Inc. Stock $dats

2023 Q4 Form 10-Q Financial Statement

#000121390023086183 Filed on November 13, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$DATS
DatChat, Inc. Stock $dats